LILRB2 and acute myeloid leukemia: Previous studies in adult AML have identified CD276, Mesothelin, MICA/B, CD96, LILRB2, CCR1 and CD70 as potential target antigens [8, 22, 23], which could not be confirmed in our pediatric cohort and previously published data.